Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC) Meeting Abstract
| Authors: | Aghajanian, C.; Blank, S.; Goff, B.; Judson, P.; Nycum, L.; Sovak, M.; Yi, J.; Husain, A. |
| Abstract Title: | Results from a 2nd interim OS analysis in OCEANS: A randomized phase 3 trial of gemcitabine (G), carboplatin (C) and bevacizumab (BV) followed by BV to disease progression in patients with platinum-sensitive recurrent epithelial ovarian (OC), primary peritoneal (PPC), or fallopian tube cancer (FTC) |
| Meeting Title: | 43rd Annual Meeting of the Society of Gynecologic Oncology (SGO) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 125 |
| Issue: | 3 |
| Meeting Dates: | 2012 Mar 24-27 |
| Meeting Location: | Austin, TX |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-06-01 |
| Start Page: | 773 |
| Language: | English |
| ACCESSION: | WOS:000304745100062 |
| DOI: | 10.1016/j.ygyno.2012.03.038 |
| PROVIDER: | wos |
| Notes: | - Late-breaking Meeting Abstract: 5 - "Source: Wos" |
